Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.
about
Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsGuidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresisSelective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.Value of colonoscopy for prediction of prognosis in patients with ulcerative colitisLeukocyte apheresis in the management of ulcerative colitis.Steroid-sparing strategies in the management of ulcerative colitis: efficacy of leukocytapheresis.Bovine lactoferrin and Crohn's disease: a case study.Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
P2860
Q26768280-62A1E2A7-298F-45BA-B867-4F4086A72379Q34122035-A0A0A997-96C3-4332-AD9C-1D13163FF93DQ34831143-E09C01D6-006A-4B6D-A34B-4FCA44DA4D54Q36210314-C5836C56-FC6B-4885-A68D-E609F19B0BEAQ36522931-A1E7B930-9692-4E17-8112-2D55249E8308Q36774059-1DEC1DA0-5CC1-4434-A4F6-528C383DCC1EQ37114622-D03ADF1F-B102-4BAE-84FE-7EF45894855EQ37136938-51AF009B-AF7F-4BE1-AE0F-B5FA6A35CCDBQ41992829-4EFAF044-2884-41FA-B57A-FF0BB15429D0Q42361175-9185D669-FBAB-4B74-A23F-F77581D98FFCQ46149663-7D050735-5A97-45E9-A1C1-4C54AE19FEFBQ48172718-F462C9F9-3DC3-4556-8D5E-094150397EAEQ51201324-C2D99141-7ED4-474C-9441-450065929AAEQ54274263-E463D225-7474-4A91-B69C-8327C8DA6F26
P2860
Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Safety and clinical efficacy o ...... herapy for ulcerative colitis.
@en
Safety and clinical efficacy o ...... herapy for ulcerative colitis.
@nl
type
label
Safety and clinical efficacy o ...... herapy for ulcerative colitis.
@en
Safety and clinical efficacy o ...... herapy for ulcerative colitis.
@nl
prefLabel
Safety and clinical efficacy o ...... herapy for ulcerative colitis.
@en
Safety and clinical efficacy o ...... herapy for ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Safety and clinical efficacy o ...... herapy for ulcerative colitis.
@en
P2093
Koichi Matsumoto
Satoru Umegae
Takayuki Yamamoto
P2860
P304
P356
10.3748/WJG.V12.I4.520
P407
P577
2006-01-01T00:00:00Z